Mature Oocyte Cryopreservation for Fertility Preservation
- PMID: 27837562
- DOI: 10.1007/978-3-319-45457-3_13
Mature Oocyte Cryopreservation for Fertility Preservation
Abstract
In recent decades, advances in cancer treatment have led to a dramatic improvement in long term survival. This has led to an increasing focus on quality of life after surviving cancer treatment, with fertility being an important aspect. Given the known reproductive risks of cancer therapies, there has been a growing interest in the field of fertility preservation (also referred to as oncofertility). Mature oocyte cryopreservation is no longer considered experimental and has become a realistic option for reproductive aged women prior to undergoing cancer treatment. Additionally, as cryopreservation techniques improve, mature oocyte cryopreservation is increasing being marketed to healthy women without cancer wishing to delay child bearing, also termed "social egg freezing". This chapter provides a review of the current technology, use, and outcomes of mature oocyte cryopreservation. It also outlines the ethical debate surrounding social egg freezing and directions for future research in female fertility preservation.
Keywords: Egg freezing; Fertility preservation; Oocyte cryopreservation; Vitrification.
Similar articles
-
Safeguarding Fertility With Whole Ovary Cryopreservation and Microvascular Transplantation: Higher Follicular Survival With Vitrification Than With Slow Freezing in a Ewe Model.Transplantation. 2016 Sep;100(9):1889-97. doi: 10.1097/TP.0000000000001296. Transplantation. 2016. PMID: 27336395
-
Oocyte vitrification for elective fertility preservation: the past, present, and future.Curr Opin Obstet Gynecol. 2017 Feb;29(1):59-63. doi: 10.1097/GCO.0000000000000339. Curr Opin Obstet Gynecol. 2017. PMID: 27922944 Review.
-
Chapter 16 Directional Freezing of Ovarian Tissue and Freeze-Drying of Stem Cells for Fertility Preservation.Methods Mol Biol. 2017;1568:223-229. doi: 10.1007/978-1-4939-6828-2_16. Methods Mol Biol. 2017. PMID: 28421500
-
Oocyte cryopreservation: where are we now?Hum Reprod Update. 2016 Jun;22(4):440-9. doi: 10.1093/humupd/dmw007. Epub 2016 Mar 22. Hum Reprod Update. 2016. PMID: 27006004 Review.
-
Prospective controlled study to evaluate laboratory and clinical outcomes of oocyte vitrification obtained in in vitro fertilization patients aged 30 to 39 years.Fertil Steril. 2013 Jun;99(7):1891-7. doi: 10.1016/j.fertnstert.2013.02.008. Epub 2013 Mar 5. Fertil Steril. 2013. PMID: 23481277
Cited by
-
Can pycnogenol prevent cisplatin-induced damage in uterus and ovaries?Arch Med Sci. 2019 Dec 6;18(5):1364-1371. doi: 10.5114/aoms.2019.90414. eCollection 2022. Arch Med Sci. 2019. PMID: 36160362 Free PMC article.
-
How great thou ART: biomechanical properties of oocytes and embryos as indicators of quality in assisted reproductive technologies.Front Cell Dev Biol. 2024 Feb 15;12:1342905. doi: 10.3389/fcell.2024.1342905. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38425501 Free PMC article. Review.
-
Coping with Oxidative Stress in Reproductive Pathophysiology and Assisted Reproduction: Melatonin as an Emerging Therapeutical Tool.Antioxidants (Basel). 2022 Dec 30;12(1):86. doi: 10.3390/antiox12010086. Antioxidants (Basel). 2022. PMID: 36670948 Free PMC article. Review.
-
Expansion and herniation: evaluation of the best pregnancy rate predictor after quarter laser assisted hatching in frozen blastocyst transfers.JBRA Assist Reprod. 2020 May 1;24(2):170-172. doi: 10.5935/1518-0557.20190090. JBRA Assist Reprod. 2020. PMID: 32159314 Free PMC article.
-
Cancer fertility preservation: a report from a Brazilian social program.JBRA Assist Reprod. 2020 Jul 14;24(3):302-304. doi: 10.5935/1518-0557.20190089. JBRA Assist Reprod. 2020. PMID: 32293819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources